TruAlt Bioenergy IPO GMP Today

The TruAlt Bioenergy IPO GMP today is ₹109, indicating strong grey market demand. With an issue price band of ₹472–₹496, this premium points to a listing around ₹605 per share—a gain of nearly 22% above the upper band.

Investors tracking TruAlt Bioenergy IPO GMP today live and TruAlt Bioenergy IPO GMP today price are finding consistent buzz, showing the IPO is expected to deliver healthy listing gains.

TruAlt Bioenergy IPO Details

IPO Open Date: September 25, 2025
IPO Close Date: September 29, 2025
IPO Size: ₹839.28 crore
- Fresh Issue: ₹750 crore
- Offer For Sale (OFS): ₹89.28 crore
Price Band: ₹472–₹496 per share
Lot Size: 30 shares (₹14,880 at upper band)
Basis of Allotment: September 30, 2025
Listing Date: October 3, 2025 (BSE & NSE)
Lead Manager: Dam Capital Advisors Ltd
Registrar: Bigshare Services Pvt. Ltd

The IPO already raised ₹251.78 crore from anchor investors on September 24, adding credibility to its market interest.

TruAlt Bioenergy IPO Subscription Status (Day 3)

As of September 29 (Day 3, 10:35 am):

Overall: 2.25× subscribed
Retail Investors: 1.64× subscribed
Non-Institutional Investors (NII): 5.48× subscribed
Qualified Institutional Buyers (QIBs): 0.90× subscribed

The strong subscription from retail and HNIs signals robust sentiment, even though QIB participation is still building.

TruAlt Bioenergy – Company Overview

TruAlt Bioenergy, headquartered in Bengaluru, is a leading biofuels and ethanol producer with an installed ethanol capacity of 2,000 KLPD.

TruAlt Bioenergy Core Businesses:

Ethanol & Biofuels: Focus on renewable and clean energy solutions.
Transformers: Produces power, inverter-duty, furnace, generator, and special-duty transformers.
Manufacturing: 4,400 transformers delivered (94,000 MVA capacity) across India.
Facilities: Five plants (4 operational) across Gujarat & Karnataka, including a new Vadodara unit.

TruAlt Bioenergy IPO Fund Utilisation:

₹150.68 crore for multi-feed stock operations
₹425 crore for working capital
Balance for general corporate purposes

TruAlt Bioenergy Share Price Target 2025

Brokerages remain optimistic about long-term prospects in bioenergy:

Listing Target (2025 short term): ₹605–₹620
Medium-Term Target 2025: ₹700–₹750
Drivers: Government ethanol blending policy, renewable energy growth, anchor investor confidence.

Reliance Securities notes the company’s strong portfolio and sector demand, while SBI Securities highlights a FY22–25 CAGR of 58% in Revenue, 72% in EBITDA, and 103% in PAT. At the upper band, valuation stands at 29× FY25 PE, considered fair for a growth company.

TruAlt Bioenergy IPO GMP Review – Apply or Not?

Strengths: ₹109 GMP today, oversubscription from retail/HNI, government policy support, anchor backing.
Risks: Valuation slightly stretched, QIB participation moderate.
Verdict: Analysts recommend Subscribe, citing strong listing gains potential and long-term growth in renewable energy.

Other IPOs in Focus

The IPO season is buzzing with:

Jinkushal Industries IPO GMP today – ₹17 premium, 14% gain expected.
Pace Digitek IPO GMP today price – positive premium with good retail demand.
Glottis Limited IPO GMP today – modest grey market traction.
BMW Ventures IPO GMP – upcoming, gaining investor chatter.

TruAlt Bioenergy stands out due to its bioenergy sector focus and strong fundamentals.

FAQs on TruAlt Bioenergy IPO GMP

Q1. What is the IPO of TruAlt Bioenergy?
TruAlt Bioenergy IPO is a ₹839.28 crore public issue (₹750 crore fresh issue + ₹89.28 crore OFS) in the renewable energy and transformer business.

Q2. What is the GMP of TruAlt Bioenergy IPO today?
The TruAlt Bioenergy IPO GMP today is ₹109, indicating an expected listing near ₹605 per share.

Q3. What is the IPO date of TruAlt Bioenergy?
The IPO opened on September 25, 2025 and closed on September 29, 2025. Listing date is October 3, 2025.

Q4. What is the subscription status of TruAlt Bioenergy IPO?
By Day 3, the IPO was subscribed 2.25× overall (Retail 1.64×, NII 5.48×, QIB 0.90×).

Q5. What is the share price target of TruAlt Bioenergy for 2025?
Analysts suggest a TruAlt Bioenergy share price target 2025 of ₹700–₹750, depending on execution and policy support.

Q6. What is IPO GMP in the grey market?
IPO GMP (Grey Market Premium) is the unofficial premium over the IPO price where shares trade before listing. It reflects demand but is not regulated.

Q7. Is GMP good or bad for IPO?
A strong GMP (like ₹109 today) signals demand and potential gains, but it is unofficial and speculative.

Q8. What is running GMP in IPO?
Running GMP is the live premium quoted in the grey market before listing. For TruAlt Bioenergy, it’s ₹109 today.

Q9. Is high GMP always good?
Not always. High GMP may reflect hype. Fundamentals, valuations, and subscription status matter equally.

Q10. Which IPO is best to buy now?
Among current issues, TruAlt Bioenergy IPO and Jinkushal Industries IPO are seeing the strongest retail demand.

Q11. What is the price of Transrail IPO GMP today?
Currently, the market focus is on TruAlt Bioenergy IPO GMP today at ₹109; Transrail GMP updates are awaited.

Q12. TruAlt Bioenergy IPO GMP in Hindi?
आज का TruAlt Bioenergy IPO GMP ₹109 है, जो संकेत देता है कि लिस्टिंग लगभग ₹605 पर हो सकती है।

Q13. TruAlt Bioenergy IPO GMP % today?
At ₹109 GMP over ₹496, the expected listing gain is nearly 22%.

Summary:
The TruAlt Bioenergy IPO GMP today at ₹109 suggests strong listing gains with subscription 2.25× overall. With a listing date of October 3, 2025, and a share price target of ₹700–₹750 for 2025, the IPO has strong fundamentals in the bioenergy space. Analysts recommend Subscribe for both short-term gains and long-term renewable energy growth.